Brenig Therapeutics, Inc.
Biotechnology company · Dover, Delaware, United States
Brenig Therapeutics, Inc. is a biotechnology company headquartered in Dover, Delaware, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2024.
Brenig Therapeutics at a glance
What does Brenig Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $30 million sold (2024).
Frequently asked questions about Brenig Therapeutics
Where is Brenig Therapeutics headquartered?
Brenig Therapeutics, Inc. is headquartered in Dover, Delaware, United States.
What does Brenig Therapeutics do?
Brenig Therapeutics, Inc. is a biotechnology company.
When was Brenig Therapeutics founded?
The earliest incorporation on record for Brenig Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Epoch Biotech, LLCDover, Massachusetts, United States
- Cosmyc IncDover, Delaware, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences